Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy

Autor: May, MT, Gompels, M, Delpech, V, Porter, K, Orkin, C, Kegg, S, Hay, P, Johnson, M, Palfreeman, A, Gilson, R, Chadwick, D, Martin, F, Hill, T, Walsh, J, Post, F, Fisher, M, Ainsworth, J, Jose, S, Leen, C, Nelson, M, Anderson, J, Sabin, C, UK Collaborative HIV Cohort (UK CHIC) Study

Objective:The objective of this study is to estimate life expectancies of HIV-positive patients conditional on response to antiretroviral therapy (ART).\ud \ud Methods: Patients aged more than 20 years who started ART during 2000–2010 (excluding ID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f175e96d57ab1d4d2967cf4c03fcf9a5
https://openaccess.sgul.ac.uk/id/eprint/107161/1/aids-28-1193.pdf

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

Autor: Sterne, JA, Lundgren, J, Gill, J, Justice, AC, May, MT, Hogg, RS, The Antiretroviral Therapy (ART) Cohort Collaboration, De Wolf, F, Sabin, CA, Costagliola, D, Egger, Matthias, Dabis, F, Fätkenheuer, G, D'Arminio Monforte, A, Staszewski, S, Phillips, AN

BACKGROUND: Highly active antiretroviral therapy (HAART) for the treatment of HIV infection was introduced a decade ago. We aimed to examine trends in the characteristics of patients starting HAART in Europe and North America, and their treatment res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d30b298f8630632ab1ec31c6db3b611

The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.

Autor: Murray, M, Hogg, RS, Lima, VD, May, MT, Moore, DM, Abgrall, S, Bruyand, M, D'Arminio Monforte, A, Tural, C, Gill, MJ, Harris, RJ, Reiss, P, Justice, A, Kirk, O, Saag, M, Smith, CJ, Weber, R, Rockstroh, J, Khaykin, P, Sterne, JAC

Publikováno v: HIV Medicine; Feb2012, Vol. 13 Issue 2, p89-97, 9p, 2 Charts, 2 Graphs

Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model.

Autor: Ingersoll MA; Department of Pharmacology and Neuroscience., Lutze RD; Department of Pharmacology and Neuroscience., Pushpan CK; Department of Pharmacology and Neuroscience., Kelmann RG; Department of Pharmacology and Neuroscience., Liu H; Department of Biomedical Sciences, and., May MT; Department of Pharmacology and Neuroscience., Hunter WJ; Department of Pathology, School of Medicine, Creighton University, Omaha, Nebraska, USA., He DZ; Department of Biomedical Sciences, and., Teitz T; Department of Pharmacology and Neuroscience.

Publikováno v: JCI insight [JCI Insight] 2023 Dec 22; Vol. 8 (24). Date of Electronic Publication: 2023 Dec 22.

Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study.

Autor: Ingle SM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Miro JM; Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., May MT; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Cain LE; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Global Epidemiology, AbbVie, Chicago, Illinois, USA., Schwimmer C; University of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Bordeaux, France., Zangerle R; Department of Dermatology, Venereology, and Allergy, Medical University Innsbruck, Innsbruck, Austria., Sambatakou H; 2nd Department of Internal Medicine, HIV Unit, Medical School, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Cazanave C; Infectious and Tropical Diseases Department, CHU de Bordeaux, Bordeaux, France., Reiss P; Stichting HIV Monitoring, Amsterdam, The Netherlands., Brandes V; Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany., Bucher HC; Basel Institute for Clinical Epidemiology & Biostatistics, Division of Infectious Diseases & Hospital Hygiene, University Hospital Basel, Basel, Switzerland., Sabin C; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Vidal F; Infectious Diseases Unit, Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.; CIBER Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Mocroft A; Centre of Excellence for Health, Immunity and Infections (CHIP) and PERSIMUNE, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Wittkop L; ISPED, INSERM, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France., d'Arminio Monforte A; Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy., Torti C; Department of Surgical and Medical Sciences, University 'Magna Graecia,', Catanzaro, Italy., Mussini C; Infectious Diseases Unit, University of Modena and Reggio Emilia, Modena, Italy., Furrer H; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Konopnicki D; Infectious Diseases Department, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium., Teira R; Service of Internal Medicine, Hospital Universitario de Sierrallana, Torrelavega, Spain., Saag MS; Center for AIDS Research, University of Alabama at Birmingham, Birmingham, Alabama, USA., Crane HM; Division of Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA., Moore RD; School of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Jacobson JM; Case Western Reserve University, Cleveland, Ohio, USA., Mathews WC; Department of Medicine, University of California San Diego, San Diego, California, USA., Geng E; Division of Infectious Diseases, Department of Medicine and the Center for Dissemination and Implementation, Institute for Public Health, Washington University in St Louis, St Louis, Missouri, USA., Eron JJ; Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA., Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Kroch A; University of Toronto, Toronto, Ontario, Canada., Lang R; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Gill MJ; Department of Medicine, University of Calgary, Southern Alberta HIV Clinic, Calgary, Alberta, Canada., Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 05; Vol. 77 (1), pp. 64-73.